Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.4/5
Bristol-Myers Squibb

Bristol-Myers Squibb (BMY UN)

3
Analysis
Health CareUnited States
Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol Myers Squibb focuses on products and experimental therapies address cancer, heart disease, HIV and AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.
more
08 Dec 2015 03:42

Investing in the Internet of Things (IoT)

In today's digitized world, everything is connected and  'smart' - our phones are packed with ever more functionality, we can surf the net directly...

Logo
1.4k Views
Share
12 Nov 2015 01:34

Healthcare Observer: As Long-Term Patent Exposure Ebbs, Innovation in Big Pharma Pipelines Support

Pipeline innovation outpacing patent losses represents a core element of the wide moat ratings for most of the Big Pharma firms. Slowing patent...

Share
11 Oct 2015 15:13

HILLARY! Scourge of Wall, Savior of Main - Preventer of Market Crashes, and Economic Crises

On October 8th, Hillary Clinton offered an Op-Ed on Bloomberg Views (available on the website here) which was a shorter version of...

Logo
341 Views
Share
08 Oct 2015 18:02

Many (un)happy returns in EM; governance and the vicious circle

This report examines the underlying governance factors that have driven EM underperformance over the last five years.Brazil, Russia, Malaysia and...

Share
07 Oct 2015 03:15

Morningstar Healthcare Observer: Biotech Industry Undervalued

The median price/fair value in our biotech universe is 0.87, and in late September valuations fell to their cheapest levels since 2011. While this...

Share
x